1 Rothman Orthopaedic Institute, Philadelphia, PA, USA.
2 Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
Foot Ankle Int. 2019 Jun;40(6):629-633. doi: 10.1177/1071100719838302. Epub 2019 Mar 22.
The management of pain in patients with foot and ankle pathology can be challenging. Cumulative data suggest that, in addition to nociceptive mechanisms, other neuropathic mechanisms can contribute to pain in a subset of people with orthopedic conditions, and can be found in 10.5% to 53% of patients with chronic pain, depending on the location of the pathology. Preoperative diagnosis of neuropathic pain (NP) can potentially change decision making and management of foot and ankle pathologies.
We used a validated patient-reported pain questionnaire (painDETECT) as a cross-sectional study to investigate the prevalence of NP symptoms in a population of patients undergoing foot and ankle surgery. A total of 533 patients were prospectively included and completed the painDETECT questionnaire.
Sixty-six patients (12.4%) were classified as having a component of NP symptoms according to their painDETECT score. Current smokers (23.2%) had a significantly higher rate of developing NP symptoms than current nonsmokers (11.1%) ( P = .016). The location of the pathology and obesity had a moderate effect on the prevalence of NP symptoms. Patients with ankle-level pathology, excluding tarsal tunnel syndrome, had a marginally increased risk of having NP symptoms (15.4%) compared to patients with forefoot pathologies, excluding Morton's neuroma (7.5%, P = 0.06). Obesity also had a moderate effect on the NP risk, with 15.6% risk of NP symptoms for patients with BMI of 30 or more compared to 10% risk for patients with a BMI of less than 30 ( P = .06). Patients with NP symptoms reported significantly higher levels of current pain (7.2 vs 4.6, P < .001).
A considerable number of patients with foot and ankle problems requiring surgery had a neuropathic component of pain. Evaluation of their risk factors and level of pain may help with the diagnosis, decision making, and pain control. Further research is needed to evaluate the effect of preoperative NP on the short- and long-term results of surgeries.
Level II, prospective cohort survey study.
足部和踝关节病变患者的疼痛管理具有挑战性。累积数据表明,除伤害感受机制外,其他神经病理性机制也可能导致一部分骨科疾病患者出现疼痛,并且在慢性疼痛患者中,10.5%至 53%的患者存在神经病理性疼痛(NP),具体取决于病变部位。术前诊断 NP 可能会改变足部和踝关节病变的决策和管理。
我们使用经过验证的患者报告疼痛问卷(painDETECT)作为横断面研究,调查接受足部和踝关节手术的患者中 NP 症状的患病率。共有 533 例患者前瞻性纳入并完成了 painDETECT 问卷。
根据 painDETECT 评分,66 例(12.4%)患者被归类为存在 NP 症状成分。与当前不吸烟者(11.1%)相比,当前吸烟者(23.2%)出现 NP 症状的比例显著更高(P =.016)。病变部位和肥胖对 NP 症状的患病率有中度影响。与前足病变(不包括 Morton 神经瘤)患者相比,踝关节病变(不包括跗管综合征)患者出现 NP 症状的风险略有增加(15.4%,P = 0.06)。肥胖对 NP 风险也有中度影响,BMI 为 30 或以上的患者出现 NP 症状的风险为 15.6%,而 BMI 小于 30 的患者风险为 10%(P =.06)。出现 NP 症状的患者报告的当前疼痛水平显著更高(7.2 比 4.6,P <.001)。
需要手术治疗的足部和踝关节疾病患者中有相当一部分存在疼痛的神经病理性成分。评估其危险因素和疼痛程度可能有助于诊断、决策和疼痛控制。需要进一步研究来评估术前 NP 对手术短期和长期结果的影响。
II 级,前瞻性队列研究。